FR2320738A1 - Compositions pharmaceutiques pour traiter l'hypertension - Google Patents

Compositions pharmaceutiques pour traiter l'hypertension

Info

Publication number
FR2320738A1
FR2320738A1 FR7624515A FR7624515A FR2320738A1 FR 2320738 A1 FR2320738 A1 FR 2320738A1 FR 7624515 A FR7624515 A FR 7624515A FR 7624515 A FR7624515 A FR 7624515A FR 2320738 A1 FR2320738 A1 FR 2320738A1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
treating hypertension
hypertension
treating
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7624515A
Other languages
English (en)
Other versions
FR2320738B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2320738A1 publication Critical patent/FR2320738A1/fr
Application granted granted Critical
Publication of FR2320738B1 publication Critical patent/FR2320738B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7624515A 1975-08-13 1976-08-11 Compositions pharmaceutiques pour traiter l'hypertension Granted FR2320738A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/604,292 US4016288A (en) 1975-08-13 1975-08-13 Compositions and method of treating hypertension

Publications (2)

Publication Number Publication Date
FR2320738A1 true FR2320738A1 (fr) 1977-03-11
FR2320738B1 FR2320738B1 (fr) 1979-05-18

Family

ID=24419029

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7624515A Granted FR2320738A1 (fr) 1975-08-13 1976-08-11 Compositions pharmaceutiques pour traiter l'hypertension

Country Status (10)

Country Link
US (1) US4016288A (fr)
JP (1) JPS5225035A (fr)
AU (1) AU508424B2 (fr)
BE (1) BE845117A (fr)
CA (1) CA1069825A (fr)
DE (1) DE2636328A1 (fr)
FR (1) FR2320738A1 (fr)
GB (1) GB1505959A (fr)
NL (1) NL7608381A (fr)
ZA (1) ZA764852B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670578A (en) * 1983-08-29 1987-06-02 Merck & Co., Inc. Process for crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters
US20050136103A1 (en) * 2003-09-17 2005-06-23 Ben-Sasson Shmuel A. Compositions capable of facilitating penetration across a biological barrier
PT3209302T (pt) * 2014-10-21 2019-07-19 Abbvie Inc Profármacos de carbidopa e l-dopa e a sua utilização para tratar doença de parkinson
CN111588833A (zh) * 2020-07-09 2020-08-28 北京大元藏宝堂健康管理有限公司 一种调节高血压的产品

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2113949A1 (en) * 1970-11-12 1972-06-30 Merck & Co Inc Compsns contg l-dopa and an alpha hydrazinyl propionic - acid - for treatment of hypertension

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830827A (en) * 1970-03-23 1974-08-20 Merck & Co Inc L-alpha-hydrazino-alpha-substituted-beta-(3,4-dihydroxyphenyl)propionic acid substantially free of the d isomer,the lower alkyl esters thereof,and the pharmaceutically acceptable salts thereof,wherein the substituent is lower alkyl
US3839585A (en) * 1970-08-05 1974-10-01 Merck & Co Inc Method of treating hypertension
US3795739A (en) * 1972-02-14 1974-03-05 Hoffmann La Roche Treatment of parkinson disease
US3784703A (en) * 1972-02-29 1974-01-08 Merck & Co Inc Method of treating hypertension

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2113949A1 (en) * 1970-11-12 1972-06-30 Merck & Co Inc Compsns contg l-dopa and an alpha hydrazinyl propionic - acid - for treatment of hypertension

Also Published As

Publication number Publication date
FR2320738B1 (fr) 1979-05-18
AU1655876A (en) 1978-02-09
ZA764852B (en) 1978-03-29
BE845117A (fr) 1977-02-14
JPS5225035A (en) 1977-02-24
NL7608381A (nl) 1977-02-15
GB1505959A (en) 1978-04-05
DE2636328A1 (de) 1977-02-24
US4016288A (en) 1977-04-05
AU508424B2 (en) 1980-03-20
CA1069825A (fr) 1980-01-15

Similar Documents

Publication Publication Date Title
FR2328792A1 (fr) Compositions pour l'assouplissement des etoffes
BE849632A (fr) Composition pharmaceutique pour l'administration orale
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
FR2299023A1 (fr) Compositions d'aminoacides
BE859817A (fr) Compositions notamment utiles pour le traitement de l'acne
BE854414A (fr) Compositions pharmaceutiques pour le traitement de l'hypertrophie benigne de la prostate
FR2304357A1 (fr) Appareil pour traiter l'ascite
FR2297904A1 (fr) Composition pour
PT65719A (fr) Procede pour la preparation de nouvelles preparations galeniques
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
BE873092A (fr) Composition pour le traitement de l'hypertension
BE837701A (fr) Composition pour la prophylaxie dentaire
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
BE885291A (fr) Compositions pharmaceutiques pour le traitement des dysfonctionnements cardiaques
FR2332965A1 (fr) Formulations d'uree-polyphosphate-potassium pour le traitement du feuillage
BE858692A (fr) Composition pour le traitement de l'acne
FR2320738A1 (fr) Compositions pharmaceutiques pour traiter l'hypertension
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
BE854412A (fr) Compositions pharmaceutiques pour un traitement gynecologique
RO68993A (fr) Composition catalytique utilisee pour l'obtention des acides nonsatures
FR2305170A1 (fr) Alliage pour formation d'amalgame dentaire
FR2314161A1 (fr) Compositions pour boutons d'allumette
SE7602128L (sv) Legerinskompositioner
FR2334362A1 (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie

Legal Events

Date Code Title Description
ST Notification of lapse